Indaptus Therapeutics (INDP) announces the appointment of Roger Waltzman, M.D. as its Chief Medical Officer, effective August 7, 2023. Dr. Waltzman joins Indaptus from Molecular Templates (MTEM), a publicly traded biotechnology company focused on discovery and development of immunotoxins.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on INDP:
